Paragon Genomics
3521 Investment Boulevard
Suite 1
Hayward
California
94545
United States
Tel: 415-855-0957
Website: https://www.paragongenomics.com/
About Paragon Genomics
At Paragon Genomics, we develop and commercialize rapid, easy-to-use, and ultra-high multiplex PCR-based target enrichment solutions for the Next-Generation Sequencing (NGS) markets. Our proprietary CleanPlex™ background-removing technology enables NGS customers to develop targeted sequencing assays that are accurate, sensitive, simple, and cost effective. Our technology is applicable to many fast-growing NGS segments such as cancer research, liquid biopsy, biomarker discovery, genomics-guided breeding, companion diagnostics, and immunotherapy monitoring.
YEAR FOUNDED:
2015
LEADERSHIP:
Co-Founder & CEO: Tao Chen
Co-Founder, President and CTO: Dr. Zhitong Liu
Chief Bioinformatics Officer: Dr. Guoying Liu
Director of R&D and Operations: Jeffrey Liu
TECHNOLOGY
Please click here for Paragon Genomics' technology. PRODUCTS
Please click here for Paragon Genomics' products.
1 article about Paragon Genomics
-
At ESHG 2019 Paragon Genomics Presents Data Highlighting Accuracy, Scalability and Speed of CleanPlex® Target Enrichment Technology and Introduces CleanPlex Products for MGI Sequencers
6/13/2019
Paragon Genomics, Inc. announced the first availability of its CleanPlex® products for use with sequencers from MGI Tech Co., Ltd. (MGI), a leading producer of high-throughput gene sequencers.